Healthcare >> Analyst Interviews >> July 3, 2006

PULMONARY ARTERIAL HYPERTENSION: ANDREW FEIN – C.E. UNTERBERG, TOWBIN

TWST: Please start with an overview of what you're covering at this

point in the biotech space.

Mr. Fein: At this point, we're covering the five companies involved with

pulmonary arterial